XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total Precipio, Inc.
Noncontrolling Interest in Joint Venture
Total
Balance at beginning of period at Dec. 31, 2022   $ 11 $ 108,588 $ (92,297) $ 16,302 $ 65 $ 16,367
Balance at beginning of period (in shares) at Dec. 31, 2022 47 1,141,013          
Increase (Decrease) in Stockholders' Equity              
Net loss       (6,778) (6,778)   (6,778)
Issuance of common stock in connection restricted stock awards     16   16   16
Issuance of common stock in connection restricted stock awards (in shares)   2,492          
Issuance of common stock in connection with purchase agreements, net of issuance costs   $ 3 1,757   1,760   1,760
Issuance of common stock in connection with purchase agreements, net of issuance costs (in shares)   206,250          
Issuance of common stock in connection with at the market offering, net of issuance costs     485   485   485
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)   30,852          
Stock-based compensation     1,152   1,152   1,152
Payment of fractional common shares in conjunction with reverse stock split (in shares)   (52)          
Balance at end of period at Sep. 30, 2023   $ 14 111,998 (99,075) 12,937 65 13,002
Balance at end of period (in shares) at Sep. 30, 2023 47 1,380,555          
Balance at beginning of period at Jun. 30, 2023   $ 14 111,632 (97,620) 14,026 65 14,091
Balance at beginning of period (in shares) at Jun. 30, 2023 47 1,378,115          
Increase (Decrease) in Stockholders' Equity              
Net loss       (1,455) (1,455)   (1,455)
Issuance of common stock in connection restricted stock awards     16   16   16
Issuance of common stock in connection restricted stock awards (in shares)   2,492          
Stock-based compensation     350   350   350
Payment of fractional common shares in conjunction with reverse stock split (in shares)   (52)          
Balance at end of period at Sep. 30, 2023   $ 14 111,998 (99,075) 12,937 $ 65 13,002
Balance at end of period (in shares) at Sep. 30, 2023 47 1,380,555          
Balance at beginning of period at Dec. 31, 2023   $ 14 112,565 (98,150) 14,429   14,429
Balance at beginning of period (in shares) at Dec. 31, 2023 47 1,420,125          
Increase (Decrease) in Stockholders' Equity              
Net loss       (3,925) (3,925)   (3,925)
Issuance of common stock in connection with at the market offering, net of issuance costs     78   78   78
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)   11,822          
Issuance of common stock for consulting services   $ 1 308   309   309
Issuance of common stock for consulting services (in shares)   50,186          
Stock-based compensation     1,054   1,054   1,054
Balance at end of period at Sep. 30, 2024   $ 15 114,005 (102,075) 11,945   11,945
Balance at end of period (in shares) at Sep. 30, 2024 47 1,482,133          
Balance at beginning of period at Jun. 30, 2024   $ 14 113,550 (101,449) 12,115   12,115
Balance at beginning of period (in shares) at Jun. 30, 2024 47 1,469,540          
Increase (Decrease) in Stockholders' Equity              
Net loss       (626) (626)   (626)
Issuance of common stock for consulting services   $ 1 57   58   58
Issuance of common stock for consulting services (in shares)   12,593          
Stock-based compensation     398   398   398
Balance at end of period at Sep. 30, 2024   $ 15 $ 114,005 $ (102,075) $ 11,945   $ 11,945
Balance at end of period (in shares) at Sep. 30, 2024 47 1,482,133